[Obstetric management in severe fetal growth retardation. Report of experiences based on 278 newborn infants with severe dystrophy 1970-1985].
The article discusses and reviews the obstetrical modalities in confirmed severe growth retardation and the effects exercised by marked dystrophy of newborn (less than or equal to 3rd percentile of weight) at the Department of Gynaecology of the University of Cologne between 1970 and 1985 on perinatal mortality, rate of asphyxiation and neonatal complications. In view of the optimal diagnostic possibilities available during the past decade, the examinations were subdivided into two groups (1970-1975 and 1976-1985). In severe foetal growth retardation-mainly confirmed sonographically-the proportion of primary Caesarean sections increased from 10% to 38%, whereas indication for inducing labour clearly dropped from 25% to 6%. The desired slight reduction in incidence of prenatally severely dystrophic newborn from 1.6% to 1.2% is regarded as the beginning of the effect of ultrasound screening during pregnancy. The higher perinatal mortality of the severely dystrophic newborn of the years 1976-1985 is explained by the increased incidence of dystrophic newborn who are considerably underweight (less than 1000 g) from 1.3% (1970-1985) to 10.4% (1976-1985). If perinatal mortality rate is corrected accordingly, perinatal mortality for both groups is about equal, namely, 3.3% and 3.2% respectively. Among the severely dystrophic newborn there were distinct differences on comparing the two groups in respect of the degree of maturity depending on the pregnancy period, and of the weight at birth. In 1970-75 85% of the dystrophic children were born after the 37th pregnancy week, i.e. mature-dystrophic, and only 15% showed in addition the signs of immaturity.(ABSTRACT TRUNCATED AT 250 WORDS)
Bolte
A
A
Universitäts-Frauenklinik Köln.
Fuhrmann
U
U
Hamm
W
W
Kusche
M
M
Schlensker
K H
KH
Stenzel
B
B
D001034:Apgar Score; D001238:Asphyxia Neonatorum / Q000628:therapy; D001724:Birth Weight; D005113:Extraction, Obstetrical; D005260:Female; D005317:Fetal Growth Retardation / Q000628:therapy*; D005323:Fetal Monitoring; D006801:Humans; D007231:Infant, Newborn; D007744:Obstetric Labor Complications / Q000628:therapy*; D011247:Pregnancy; D011296:Prenatal Diagnosis; D014463:Ultrasonography
Geburtshilfliches Management bei schwerer fetaler Wachstumsretardierung. Ergebnisbericht anhand von 278 Neugeborenen mit schwerer Dystrophie der Jahrgänge 1970-1985.